Cargando…

Plasma LOX-Products and Monocyte Signaling Is Reduced by Adjunctive Cyclooxygenase-2 Inhibitor in a Phase I Clinical Trial of Tuberculosis Patients

INTRODUCTION: Eicosanoids and intracellular signaling pathways are potential targets for host-directed therapy (HDT) in tuberculosis (TB). We have explored the effect of cyclooxygenase 2 inhibitor (COX-2i) treatment on eicosanoid levels and signaling pathways in monocytes. METHODS: Peripheral blood...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jøntvedt Jørgensen, Marthe, Nore, Kristin G., Aass, Hans Christian D., Layre, Emilie, Nigou, Jérôme, Mortensen, Rasmus, Tasken, Kjetil, Kvale, Dag, Jenum, Synne, Tonby, Kristian, Dyrhol-Riise, Anne Ma
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Cellular and Infection Microbiology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8299478/ https://www.ncbi.nlm.nih.gov/pubmed/34307194 http://dx.doi.org/10.3389/fcimb.2021.669623

Ejemplares similares

Monocytic myeloid‐derived suppressor cells reflect tuberculosis severity and are influenced by cyclooxygenase‐2 inhibitors
por: Jøntvedt Jørgensen, Marthe, et al.
Publicado: (2020)

Elevated Levels of Anti-Inflammatory Eicosanoids and Monocyte Heterogeneity in Mycobacterium tuberculosis Infection and Disease
por: Nore, Kristin Grotle, et al.
Publicado: (2020)

A Phase I/II randomized trial of H56:IC31 vaccination and adjunctive cyclooxygenase-2-inhibitor treatment in tuberculosis patients
por: Jenum, Synne, et al.
Publicado: (2021)

Targeting Tuberculosis and HIV Infection-Specific Regulatory T Cells with MEK/ERK Signaling Pathway Inhibitors
por: Lieske, Nora V., et al.
Publicado: (2015)

The COX- inhibitor indomethacin reduces Th1 effector and T regulatory cells in vitro in Mycobacterium tuberculosis infection
por: Tonby, Kristian, et al.
Publicado: (2016)

Cyclooxygenase inhibitors impair CD4 T cell immunity and exacerbate Mycobacterium tuberculosis infection in aerosol-challenged mice
por: Mortensen, Rasmus, et al.
Publicado: (2019)

Immune activation and HIV-specific T cell responses are modulated by a cyclooxygenase-2 inhibitor in untreated HIV-infected individuals: An exploratory clinical trial
por: Prebensen, Christian, et al.
Publicado: (2017)

IP-10 measured by Dry Plasma Spots as biomarker for therapy responses in Mycobacterium Tuberculosis infection
por: Tonby, Kristian, et al.
Publicado: (2015)

Early dynamics of T helper cell cytokines and T regulatory cells in response to treatment of active Mycobacterium tuberculosis infection
por: Feruglio, S L, et al.
Publicado: (2015)

A Plasma 5-Marker Host Biosignature Identifies Tuberculosis in High and Low Endemic Countries
por: Chendi, Bih H., et al.
Publicado: (2021)

DIAGNOSTIC ACCURACY AND ADDED VALUE OF INFECTION BIOMARKERS IN PATIENTS WITH POSSIBLE SEPSIS IN THE EMERGENCY DEPARTMENT
por: Christensen, Erik E., et al.
Publicado: (2022)

Increased interleukin-6 and macrophage chemoattractant protein-1 are associated with respiratory failure in COVID-19
por: Jøntvedt Jørgensen, Marthe, et al.
Publicado: (2020)

Enhanced Gut-Homing Dynamics and Pronounced Exhaustion of Mucosal and Blood CD4(+) T Cells in HIV-Infected Immunological Non-Responders
por: Lorvik, Kristina Berg, et al.
Publicado: (2021)

Regulation of Gag- and Env-Specific CD8(+) T Cell Responses in ART-Naïve HIV-Infected Patients: Potential Implications for Individualized Immunotherapy
por: Prebensen, Christian, et al.
Publicado: (2016)

Critical COVID‐19 is associated with distinct leukocyte phenotypes and transcriptome patterns
por: Christensen, E. E., et al.
Publicado: (2021)

The therapeutic HIV Env C5/gp41 vaccine candidate Vacc-C5 induces specific T cell regulation in a phase I/II clinical study
por: Brekke, Kristin, et al.
Publicado: (2017)

Soluble Markers of the Toll-Like Receptor 4 Pathway Differentiate between Active and Latent Tuberculosis and Are Associated with Treatment Responses
por: Feruglio, Siri L., et al.
Publicado: (2013)

Activated dendritic cells and monocytes in HIV immunological nonresponders: HIV-induced interferon-inducible protein-10 correlates with low future CD4(+) recovery
por: Stiksrud, Birgitte, et al.
Publicado: (2019)

Gut microbiota composition during hospitalization is associated with 60-day mortality after severe COVID-19
por: Trøseid, Marius, et al.
Publicado: (2023)

Elevated plasma sTIM-3 levels in patients with severe COVID-19
por: Ueland, Thor, et al.
Publicado: (2021)

SARS-CoV-2 infection induces long-lived B and T-cell responses up to 15 months post-infection, irrespective of disease severity
por: Mohn, Kristin G-I, et al.
Publicado: (2023)

A 2-Dose AERAS-402 Regimen Boosts CD8(+) Polyfunctionality in HIV-Negative, BCG-Vaccinated Recipients
por: Sivakumaran, Dhanasekaran, et al.
Publicado: (2021)

The Medicinal Timber Canarium patentinervium Miq. (Burseraceae Kunth.) Is an Anti-Inflammatory Bioresource of Dual Inhibitors of Cyclooxygenase (COX) and 5-Lipoxygenase (5-LOX)
por: Mogana, R., et al.
Publicado: (2013)

Human Immunodeficiency Virus–Infected Immunological Nonresponders Have Colon-Restricted Gut Mucosal Immune Dysfunction
por: Meyer-Myklestad, Malin Holm, et al.
Publicado: (2020)

USF2 inhibits C/EBP-mediated transcriptional regulation of the RIIβ subunit of cAMP-dependent protein kinase
por: Dahle, Maria Krudtaa, et al.
Publicado: (2002)

Screening for latent tuberculosis in Norwegian health care workers: high frequency of discordant tuberculin skin test positive and interferon-gamma release assay negative results
por: Gran, Gerd, et al.
Publicado: (2013)

Cytokine Patterns in Tuberculosis Infection; IL-1ra, IL-2 and IP-10 Differentiate Borderline QuantiFERON-TB Samples from Uninfected Controls
por: Wergeland, Ida, et al.
Publicado: (2016)

Anchored PKA as a gatekeeper for gap junctions
por: Pidoux, Guillaume, et al.
Publicado: (2015)

Replacing the wild type loxP site in BACs from the public domain with lox66 using a lox66 transposon
por: Chatterjee, Pradeep K, et al.
Publicado: (2010)

Proinflammatory and Immunoregulatory Roles of Eicosanoids in T Cells
por: Lone, Anna Mari, et al.
Publicado: (2013)

Targeting protein–protein interactions in complexes organized by A kinase anchoring proteins
por: Calejo, Ana I., et al.
Publicado: (2015)

Molecular Mechanisms for cAMP-Mediated Immunoregulation in T cells – Role of Anchored Protein Kinase A Signaling Units
por: Wehbi, Vanessa L., et al.
Publicado: (2016)

Predicting severe COVID-19 in the Emergency Department
por: Holten, Aleksander Rygh, et al.
Publicado: (2020)

LOX-1 boosts immunity
por: Oh, SangKon, et al.
Publicado: (2015)

LOX-1 in Ischemic Stroke
por: Sawamura, Tatsuya, et al.
Publicado: (2017)

Lox’d in translation: contradictions in the nomenclature surrounding common lox-site mutants and their implications in experiments
por: Shaw, Daniel, et al.
Publicado: (2020)

Identification of the LOX Gene Family in Peanut and Functional Characterization of AhLOX29 in Drought Tolerance
por: Mou, Yifei, et al.
Publicado: (2022)

The cyclooxygenases
por: Chandrasekharan, NV, et al.
Publicado: (2004)

Spatiotemporal regulation of cAMP signaling controls the human trophoblast fusion
por: Gerbaud, Pascale, et al.
Publicado: (2015)

Severely ill COVID-19 patients have altered circulating levels of proteins controlling the epitranscriptome()
por: Quiles-Jiménez, A., et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_iug2nd86rdtompc5pgjn6j79an